Although the NAT10 signaling pathway reportedly acts as a pro-oncogenic factor in pancreatic cancer [23], the specific cytosine sites within mRNA regulated by NAT10 in PNI remain unreported. The gene discussed is NAT10; the disease is familial pancreatic carcinoma.